We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CALR is potential prognostic, high expression is favorable in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
828.7
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
2234.2
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
2128.7
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
2069.6
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
2023.1
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
1999.8
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1946.5
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
1915.2
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
1906.0
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
1902.0
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
1820.6
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
1739.4
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
1652.7
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
1588.6
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
1549.6
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1539.2
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
1531.5
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
1525.2
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
1503.0
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
1500.4
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
1468.8
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
1455.0
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
1443.3
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
1396.3
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
1387.4
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
1383.0
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
1370.3
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
1360.8
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
1332.1
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
1308.8
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
1258.6
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
1247.7
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
1237.1
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
1231.4
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
1228.4
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
1214.0
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
1192.7
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
1189.3
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
1183.6
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1167.3
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1164.0
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
1163.8
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
1162.4
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
1159.2
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
1146.3
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
1143.6
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
1132.5
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
1127.4
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
1127.1
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
1123.4
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
1120.4
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
1119.4
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
1110.9
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
1108.2
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1091.1
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
1083.0
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
1082.6
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
1082.6
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
1082.2
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
1080.4
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
1076.1
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
1075.1
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
1072.5
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
1072.1
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1071.3
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1067.2
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
1064.7
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1050.6
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
1050.5
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
1047.7
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
1041.9
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
1039.1
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
1038.8
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
1038.4
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1034.3
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
1032.2
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
1029.7
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
1020.2
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1009.7
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
1007.4
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1005.9
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1003.4
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
995.5
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
994.1
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
989.9
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
986.8
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
986.1
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
984.8
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
983.0
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
981.8
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
981.1
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
978.4
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
971.8
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
971.4
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
967.5
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
966.8
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
958.3
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
957.7
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
957.0
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
942.1
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
942.0
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
940.4
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
939.2
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
933.8
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
932.3
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
931.9
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
931.2
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
927.2
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
925.8
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
925.6
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
925.1
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
922.6
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
920.5
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
913.7
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
912.8
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
911.6
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
909.6
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
908.5
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
907.3
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
906.6
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
903.9
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
901.7
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
900.5
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
899.4
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
898.3
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
894.5
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
893.9
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
887.2
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
884.2
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
881.7
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
881.4
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
877.3
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
876.3
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
876.0
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
876.0
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
874.8
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
871.1
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
870.7
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
867.1
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
865.0
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
863.8
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
859.4
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
858.6
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
858.3
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
857.2
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
856.8
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
853.7
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
852.9
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
851.9
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
846.9
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
840.7
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
838.3
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
838.3
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
837.4
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
834.4
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
832.1
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
829.5
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
828.1
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
825.8
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
821.2
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
820.7
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
820.0
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
818.3
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
810.2
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
808.9
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
808.7
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
808.4
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
808.2
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
803.4
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
799.8
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
799.6
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
797.6
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
794.6
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
790.9
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
788.8
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
786.6
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
768.1
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
766.5
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
764.8
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
764.2
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
762.1
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
757.4
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
753.1
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
750.1
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
749.3
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
747.4
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
746.8
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
746.7
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
746.6
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
742.4
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
740.7
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
739.4
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
737.3
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
736.9
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
736.5
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
736.4
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
734.3
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
730.2
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
726.1
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
723.0
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
720.9
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
720.2
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
719.8
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
718.5
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
716.8
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
715.6
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
713.8
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
705.4
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
702.3
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
698.0
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
697.5
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
697.5
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
697.4
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
697.4
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
695.3
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
693.4
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
690.1
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
681.1
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
679.7
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
677.4
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
676.3
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
676.0
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
669.9
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
662.9
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
659.4
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
658.4
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
657.8
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
657.7
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
657.6
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
656.4
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
655.5
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
653.9
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
651.6
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
649.2
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
647.2
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
646.1
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
644.7
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
644.4
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
643.4
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
639.4
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
638.0
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
637.7
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
631.2
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
630.5
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
630.1
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
629.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
628.5
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
626.8
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
624.1
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
621.7
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
621.4
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
614.2
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
613.7
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
612.9
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
609.6
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
608.8
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
605.8
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
605.4
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
603.9
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
601.0
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
600.7
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
600.3
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
594.6
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
594.0
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
590.3
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
589.8
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
589.6
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
588.3
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
586.4
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
585.2
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
585.2
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
584.1
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
581.5
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
580.5
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
578.0
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
569.4
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
568.1
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
560.6
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
558.0
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
556.2
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
555.8
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
554.0
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
550.7
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
549.0
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
544.2
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
542.0
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
539.5
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
539.3
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
530.2
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
528.5
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
525.6
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
525.4
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
524.4
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
521.8
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
519.1
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
517.8
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
516.4
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
513.1
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
511.1
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
509.4
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
507.8
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
504.3
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
503.4
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
500.9
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
500.7
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
495.5
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
495.5
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
489.5
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
488.3
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
487.0
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
486.5
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
483.8
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
482.8
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
482.1
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
475.4
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
470.8
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
456.4
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
456.3
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
449.5
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
448.0
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
436.4
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
431.3
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
428.9
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
422.6
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
422.6
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
422.6
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
412.6
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
411.6
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
410.4
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
402.2
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
392.0
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
389.4
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
387.0
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
385.1
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
383.9
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
379.7
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
366.6
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
361.9
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
350.5
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
332.9
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
332.0
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
329.1
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
328.9
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
315.4
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
307.1
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
304.9
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
291.7
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
273.4
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
270.1
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CALR is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
790.1
Number of samples
81
Samples
Sample
Description
pTPM
DO46338
59 years, female, NA, stage:III, dead, 596 days
1937.5
DO46366
65 years, female, NA, stage:III, dead, 2054 days
1581.5
DO46463
49 years, female, NA, stage:III, dead, 2451 days
1556.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
1412.3
DO46362
61 years, female, NA, stage:III, dead, 1639 days
1319.0
DO46370
54 years, female, NA, stage:III, dead, 1727 days
1279.5
DO46376
58 years, female, NA, stage:III, dead, 1430 days
1240.5
DO46576
75 years, female, NA, stage:III, alive, 133 days
1232.4
DO46611
52 years, female, NA, stage:III, dead, 734 days
1225.7
DO46588
74 years, female, NA, stage:III, dead, 438 days
1198.1
DO46330
60 years, female, NA, stage:III, dead, 684 days
1195.0
DO46346
54 years, female, NA, stage:III, dead, 1187 days
1151.5
DO46328
52 years, female, NA, stage:III, dead, 972 days
1139.6
DO46348
58 years, female, NA, stage:IV, dead, 287 days
1087.9
DO46597
60 years, female, NA, stage:III, dead, 393 days
1082.7
DO46404
55 years, female, NA, stage:III, dead, 690 days
1081.8
DO46581
66 years, female, NA, stage:III, dead, 408 days
1069.7
DO46329
52 years, female, NA, stage:III, dead, 1699 days
1068.4
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1052.8
DO46606
73 years, female, NA, stage:III, alive, 804 days
1012.8
DO46443
59 years, female, NA, stage:III, dead, 2464 days
973.3
DO46333
58 years, female, NA, stage:III, dead, 359 days
961.8
DO46342
67 years, female, NA, stage:III, dead, 1398 days
948.7
DO46331
72 years, female, NA, stage:III, dead, 612 days
944.5
DO46566
78 years, female, NA, stage:III, dead, 673 days
927.3
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
919.8
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
918.9
DO46528
56 years, female, NA, stage:III, alive, 6139 days
910.9
DO46591
58 years, female, NA, stage:III, dead, 195 days
870.1
DO46354
73 years, female, NA, stage:III, dead, 843 days
862.6
DO46327
54 years, female, NA, stage:III, dead, 184 days
846.9
DO46412
64 years, female, NA, stage:III, dead, 597 days
841.7
DO46436
58 years, female, NA, stage:III, alive, 3193 days
839.6
DO46468
67 years, female, NA, stage:III, alive, 2776 days
817.5
DO46334
77 years, female, NA, stage:III, dead, 496 days
806.5
DO46533
46 years, female, NA, stage:III, alive, 3667 days
801.3
DO46568
66 years, female, NA, stage:III, dead, 320 days
771.5
DO46560
45 years, female, NA, stage:IV, dead, 286 days
767.6
DO46561
52 years, female, NA, stage:III, dead, 195 days
751.3
DO46356
68 years, female, NA, stage:III, dead, 911 days
735.7
DO46340
62 years, female, NA, stage:III, dead, 616 days
732.4
DO46364
45 years, female, NA, stage:III, dead, 806 days
719.8
DO46571
61 years, female, NA, stage:III, dead, 243 days
697.6
DO46453
66 years, female, NA, stage:III, dead, 3294 days
697.0
DO46508
50 years, female, NA, stage:III, dead, 2101 days
692.0
DO46586
55 years, female, NA, stage:III, dead, 1019 days
689.3
DO46325
54 years, female, NA, stage:III, dead, 477 days
684.8
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
675.9
DO46380
51 years, female, NA, stage:III, dead, 1423 days
657.4
DO46432
56 years, female, NA, stage:III, alive, 2218 days
633.8
DO46402
77 years, female, NA, stage:III, dead, 511 days
633.5
DO46551
58 years, female, NA, stage:III, dead, 1055 days
594.6
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
581.4
DO46332
56 years, female, NA, stage:III, dead, 689 days
579.4
DO46368
57 years, female, NA, stage:III, dead, 2879 days
553.2
DO46518
62 years, female, NA, stage:III, alive, 2960 days
545.8
DO46350
66 years, female, NA, stage:III, dead, 886 days
540.7
DO46344
46 years, female, NA, stage:III, dead, 642 days
533.5
DO46602
74 years, female, NA, stage:III, dead, 205 days
529.6
DO46396
64 years, female, NA, stage:III, dead, 583 days
529.2
DO46336
70 years, female, NA, stage:IV, dead, 664 days
522.5
DO46392
48 years, female, NA, stage:III, dead, 628 days
522.1
DO46400
70 years, female, NA, stage:III, dead, 719 days
521.9
DO46326
51 years, female, NA, stage:III, dead, 701 days
520.5
DO46352
60 years, female, NA, stage:III, dead, 677 days
513.1
DO46358
60 years, female, NA, stage:III, dead, 423 days
512.1
DO46448
45 years, female, NA, stage:III, dead, 654 days
507.3
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
499.7
DO46493
62 years, female, NA, stage:IV, alive, 839 days
491.1
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
480.3
DO46378
59 years, female, NA, stage:III, alive, 843 days
477.0
DO46386
49 years, female, NA, stage:III, dead, 1162 days
470.1
DO46372
39 years, female, NA, stage:III, dead, 1326 days
468.2
DO46398
66 years, female, NA, stage:III, alive, 437 days
416.1
DO46388
74 years, female, NA, stage:III, dead, 413 days
401.5
DO46390
65 years, female, NA, stage:III, dead, 374 days
397.0
DO46374
69 years, female, NA, stage:III, dead, 1409 days
378.6
DO46384
55 years, female, NA, stage:III, dead, 614 days
357.5
DO46408
56 years, female, NA, stage:III, dead, 489 days
326.8
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
324.5
DO46546
73 years, female, NA, stage:III, dead, 1889 days
252.9
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.5
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
1.5
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
1.4
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.2
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
1.1
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
1.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.1
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.0
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.0
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
1.0
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
1.0
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.9
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.9
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.9
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.9
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.8
15524912-685a-47ce-a824-567848_D2
Tumor
0.8
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.8
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.8
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.8
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.8
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.8
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.7
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.7
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.7
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.7
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.7
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.7
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.7
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.7
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.7
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.7
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.6
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.6
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.6
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.6
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.6
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.6
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.6
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.6
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.5
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.5
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.5
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.5
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.5
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.5
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.4
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.4
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.3
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.3
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.3
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.3
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.3
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.3
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.3
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.2
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.2
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.2
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.2
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.2
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.1
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.1
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.1
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.1
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.1
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.1
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.1
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.2
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.2
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.2
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.2
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.3
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.3
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.3
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.3
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.4
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.4
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.5
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.5
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.5
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.5
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.5
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.5
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.6
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.6
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.6
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.7
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.8
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.8
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
